Navigation Links
Benda Pharmaceutical Reports Third Quarter 2008 Financial Results
Date:11/18/2008

HUBEI PROVINCE, China, Nov. 18 /PRNewswire-FirstCall/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, today announced financial results for the three and nine month periods ended September 30, 2008. The Company intends to file its Form 10-Q with the SEC today.

Nine Months Ended September 30, 2008

Revenue in the first nine months of 2008 increased 25.7% to $19.9 million from $15.8 million in the first nine months of 2007, primarily reflecting increased sales at Benda Ebei. SiBiono generated revenue of $1.8 million in the first nine months of 2008, down from $3.3 million in the prior year period. The decline in SiBiono-related revenue reflects the Company's reorganization of personnel in the department.

Gross profit in the first nine months of 2008 was $7.2 million, a 5.7% decrease from $7.7 million in the first nine months of 2007. Gross margin was 36.5%, compared with 48.7% in the same period in 2007. Gross margin performance reflected a drop in sales of Gendicine, which has historically generated a comparatively higher gross margin.

Operating loss in the first nine months of 2008 was $0.7 million, an improvement from an operating loss of $5.3 million in the first nine months of 2007. Operating expenses in the first nine months of 2008 was approximately $7.9 million, compared with $13.0 million in the first nine months of 2007. Operating expense reflects promotional fees for Gendicine and the introduction of new products in Benda Ebei, as well as a $1.4 million penalty paid to investors for registration delays. The Company incurred significantly higher operating costs in the prior year period related to the acquisition of SiBiono.

Net loss in the first nine months of 2008 im
'/>"/>

SOURCE Benda Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Benda Pharmaceutical Files Amendment To Form S-1
2. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
3. Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
4. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
5. ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)
6. NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists
7. Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results
8. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
9. White Paper Details How DNA Sequencing Services Can Prevent Cleanroom Shutdowns at Medical Device and Pharmaceutical Manufacturers
10. Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board
11. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Swedesboro, NJ (PRWEB) May 24, 2013 Dr. ... Elmer, NJ and Swedesboro, NJ, are proud to announce an ... event will take place on Saturday, June 8th from 10 ... Dr. Warmuth, Anamaria Newport, MHS, PA-C and staff will be ... dermal fillers, laser and aesthetic treatments, and provide complimentary cosmetic ...
(Date:5/24/2013)... May 24, 2013 In a ... industry suppliers will present technologies with applications in ... annual SPIE Optics and Photonics symposium ... SPIE, the international society for optics and ... multidisciplinary optical sciences and technology meeting in North ...
(Date:5/24/2013)... May 24, 2013 Bed bug cases tend ... themselves from the looming higher risk of becoming the pests' ... new bed bug guideline. In the guide, the company enumerated ... and avoiding them while traveling. , According to My ... increase of bed bug infestation during summer: the warm weather ...
(Date:5/24/2013)... Israel , May 24, 2013 ... leader in embolic protection stents, announced that Alan ... and Craig Shore , the Company,s Chief ... Investor Conference on Thursday May 30, 2013 at The Pfister ... The format of the conference includes a ...
Breaking Biology Technology:See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 2See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 4Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 2Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 3InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4
... N.J., Feb. 5 Genta,Incorporated (Nasdaq: GNTA ) ... Dr. Raymond P. Warrell, Jr., will provide a,company overview ... &,Investor Conference. The presentation is scheduled for Wednesday, February,13th ... New York, NY., About Genta, Genta Incorporated ...
... LOUISVILLE, Colo., Feb. 5 Replidyne, Inc.,(Nasdaq: RDYN ) ... February 26, 2008 at 4:45 P.M. ET to report 2007 ... upcoming,investor conference in February 2008., Earnings conference call ... President and CEO, and other members of Replidyne,s ...
... Mass., Feb. 5 Echo Therapeutics,Inc. (OTC Bulletin ... announced today that Patrick T. Mooney, M.D, Chairman,and ... Small-Cap Investor,Conference on February 7, 2008 at 3:50 ... The conference will be held at the Four ...
Cached Biology Technology:Genta Incorporated to Present at the BIO CEO & Investor Conference 2Genta Incorporated to Present at the BIO CEO & Investor Conference 3Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 3Echo Therapeutics to Present at RedChip Small-Cap Investor Conference 2
(Date:5/23/2013)... Rollins School of Public Health at Emory University, ... Technology, have received a $4 million grant over ... Emory University (Health and Exposome Research Center: Understanding ... center grant awarded in the United States. ... National Institute of Environmental Health Sciences (NIEHS) of ...
(Date:5/23/2013)... the overall health, development, and academic success of ... ensuring that all students have opportunities to engage ... vigorous or moderate-intensity physical activity, says a new ... estimates suggest that only about half of school-age ... health and development. The report recommends that ...
(Date:5/23/2013)... cerebral palsy with autologous cord blood. Following a cardiac ... boy had been in a persistent vegetative state ... treatment with the cord blood containing stem cells, the ... learned to speak simple sentences and to move. "Our ... the long-held doubts about the effectiveness of the new ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3First successful treatment of pediatric cerebral palsy with autologous cord blood 2
... November 18, 2008 -- Researchers at the University of California, ... been used to block and reverse type 1 diabetes in ... the National Academy of Sciences , was led by Jeffrey ... an expert in the field of autoimmunity. "The findings ...
... at Birmingham (UAB) Center for Education and Research on ... to study the risks and benefits of a newer ... therapies that target the immune system of patients who ... disorders. The award will allow the UAB CERTs ...
... WEST LAFAYETTE, Ind. - Materials engineers have created a ... and, if perfected, might be used for environmental cleanup, ... would last longer than conventional filters for separating oil ... oil, traits that are usually mutually exclusive. Researchers attached ...
Cached Biology News:Musculoskeletal center wins $2.2 million for drug safety 2New filtering technology has environmental, industrial applications 2New filtering technology has environmental, industrial applications 3
... optically clear polystyrene formulation , High antibody-binding ... , Plates are certified for performance ... , Eight-well strips fit snugly in ... in use even if turned upside down ...
...
... an aqueous solution that contains a purified ... in a saline solution, pH 6.5 ... methylisothiazolone and 0.02% bromonitrodioxane as a preservative. ... and stabilizer for biologically active components in ...
... StabilGuard Biomolecule Stabilizer is a bovine protein-free ... is an aqueous solution that contains non-toxic ... saline), pH 6.6 - 7.2, and does ... maintains the activity of antibodies and other ...
Biology Products: